ANATOMY 1 Name of the Department: Department ... - Biomeedikum

SECTION I: APPENDIXES
54. C.Löfberg, J.Harro, V.Matto, L.Oreland. Cholecystokinin peptides and receptor binding in rat brain
after DSP-4 treatment. Neuropeptides, 1998, vol. 32, No 2, pp. 103-108.
55. T.Marandi, V.Vasar, L.Rägo. The pattern of use of antidepressants in Estonia in 1996. Nord Psykiatr
Tidsskr, 1998, vol. 52, No 6, pp. 465-473.
56. V.Matto, L.Allikmets. Rat exploratory behaviour after acute or repeated antidepressant treatment in
open-field and exploration-box tests. Baltic J. Lab. Anim. Sci., 1998, vol. 8, pp. 145-157.
57. V.Matto, L.Allikmets. Rapid changes in the affinity of the 5-hydroxytryptamine transporter binding
sites in rat frontal cortex after single citalopram injection. Pharmaceutical and Pharmacological
Letters, 1998, vol. 8, No 4, pp. 90-92.
58. V.Matto, L.Allikmets. Comparison of rat exploratory behaviour after noradrenergic denervation in
elevated zero-maze and open tests. Baltic J. Lab. Anim. Sci., 1998, vol. 8, pp. 16-19.
59. V.Matto, L.Allikmets. Apomorphine-induced aggressive and nonaggressive rats differ in
[ 3 H]raclopride-sensitive D2 receptor binding characteristics. Medical Science Research, 1998, vol.
26, pp. 499-501.
60. V.Matto, L.Allikmets, T.Skrebuhhova. Apomorphine-induced aggressiveness and [ 3 H]citalopram
binding after antidepressant treatment in rats. Pharmacol. Biochem. Behav., 1998, vol. 59, No 3,
pp. 747-752.
61. V.Matto, T.Skrebuhhova, L.Allikmets. The effect of antidepressants on rat aggressive behavior in
the electric footshock and apomorphine-induced aggressiveness paradigms. Meth. Find. Exp. Clin.
Pharmacol., 1998, vol. 20, No 4, pp. 329-337.
62. M.J.Otter, L.H.Alllikmets, A.M.Zharkovsky, L.G.Polevoi. Neurobutaal (kaltsiumoksübutüraat) - uus
nootroopne preparaat. II. Biosaadavus ja toimed kestval manustamisel. Nootroopsed preparaadid.
Moskva, 1998, lk. 149-158 (vene keeles).
63. P.Pokk, A.Zharkovsky. The effect of buspirone on the behaviour of control and stressed mice. J. of
Physiol. Pharmacol., 1998, vol. 49, No 1, pp. 175-186.
64. P.Pokk, A.Zharkovsky. Small platform stress attenuates the anxiogenic effect of diazepam withdrawal
in the plus-maze test. Behavioural Brain Rssearch, 1998, vol. 98, pp. 153-157.
65. R.Pähkla, M.Zilmer, T.Kullisaar, L.Rägo. Comparison of the antioxidant activity of melatonin and
pinoline in vitro. J. Pineal Res., 1998, vol. 24, pp. 96-101.
66. L.Rägo. An update of regulatory affairs in Estonia. NLN Baltic Conference 1998. Clinical Trials of
Medicines - Opportunities and Challenges in the Baltic Region. June 15-16, 1998, Vilnius Lithuania.
NLN Publication No 49. Nordic Council on Medicines, Uppsala, 1998, pp. 19-24.
67. V.Vassiljev, A.Kalda, P.Pokk, M.Väli, A.Zharkovsky. Modified method for the induction of ethanol
dependence in mice. Baltic J. Lab. Anim. Sci., 1998, vol. 8, pp. 89-92.
68. V.Vassiljev, A.Kalda, P.Pokk, M.Väli, A.Zharkovsky. Nitric oxide synthase inhibitor 7-nitroindazole
attenuates the behavioural signs of ethanol withdrawal due to pharmacokinetic interaction. Med.
Sci. Res., 1998, vol. 26, pp. 821-822.
69. V.Vassiljev, A.Kalda, P.Pokk, M.Väli, A.Zharkovsky. The effect of the nitric oxide synthase inhibitor
7-nitroindazole on ethanol pharmacokinetics in rats after acute and chronic ethanol administration.
Alcohol & Alcoholism, 1998, vol. 33, No 6, pp. 609-615.
70. E.De Sousa, V.Veksler, A.Minajeva, A.Kaasik, P.Mateo, E.Mayoux, J.Hoerter, X.Bigard,
B.Serrurier, R.Ventura-Clapier. Subcellular creatine kinase alterations implications in heart failure.
Circulation Research, 1999, vol. 85, pp. 68-76.
71. J.Harro, R.Häidkind, M.Harro, A.-R.Modiri, P.-G.Gillberg, R.Pähkla, V.Matto, L.Oreland. Chronic
mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical
effects of DSP-4 treatment. Eur. Neuropsychopharm., 1999, vol. 10, pp. 5-16.
72. J.Harro, R.Pähkla, A.-R.Modiri, M.Harro, A.Kask, L.Oreland. Dose-dependent effects of
noradrenergic denervation by DSP-4 treatment on forced swimming and β-adrenoceptor binding in
the rat. J. Neural. Transm., 1999, vol. 106, pp. 619-629.
73. A.Kaasik, A.Minajeva, E.De Sousa, R. Ventura-Clapier, V.Veksler. Nitric oxide inhibits cardiac energy
production via inhibition of mitochondrial creatine kinase. FEBS Letters, 1999, vol. 444, pp.
75-77.
74. A.Kaasik, V.Vassiljev, E.Põldoja, A.Kalda, A.Zharkovsky. Do nuclear condensation or fragmentation
and DNA fragmentation reflect the mode of neuronal death?. NeuroReport, 1999, vol. 10, No 9,
pp. 1937-1942.
75. A.Kalda, A.Kaasik, V.Vassiljev, P.Pokk, A.Zharkovsky. Neuroprotective action of group I metabotropic
glutamate receptor agonists against oxygen-glucose deprivation-induced neuronal death.
Brain Research, 1999, 28246, pp. 1-3.
76. A.Kalda, A.Zharkovsky. Metabotropic glutamate receptor agonists protect from oxygen-glucose
deprivation- and colchicines-induced apoptosis in primary cultures of cerebellar granule cells. Neuroscience,
1999, vol. 92, No 1, pp. 7-14.
56